Lupin and Sun Pharma shares gained 1.8 percent each intraday Wednesday after receiving approval from the US health regulator for drugs.
Pharma major Lupin has received approval from US Food and Drug Administration for Armodafinil that is used to treat excessive sleeping disorder.
US FDA also approved ANDA for Paroxetine Hydrochloride that filed by Sun Pharma.
Paroxetine Hydrochloride is used for treatment of OCD, panic attacks.
Meanwhile, Aurobindo Pharma also received US FDA approval for Sevelamer tablets that are used to treat patients with chronic kidney diseases and Zydus Pharma, the subsidiary of Cadila Healthcare, got approval for Pitavastatin that helps lowering bad cholesterol & raising good cholesterol.
At 14:25 hours IST, the stock price of Lupin was quoting at Rs 1,171.05, up 1.33 percent and Sun Pharmaceutical Industries was at Rs 585.95, up 1.37 percent on the BSE.
Posted by Sunil Shankar Matkar
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!